Data / Form D filings / Nalu Bio, Inc.
Nalu Bio, Inc.: Form D filing
Nalu Bio, Inc., a company in San Francisco, CA, filed a Form D with the SEC in 2023. The latest, on March 3, 2023, reports $4.8 million sold of a $17.1 million offering to 11 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 38 KEYES AVENUE, SUITE 200, San Francisco, CA, 94129
- Phone
- (415) 706-0623
- Industry
- Other
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2019
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1966319
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 3, 2023 | New notice | $17,142,145 | $4,807,998 | $12,334,147 | 11 | Jan 30, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Phyllis E. Whiteley | Executive Officer, Director | |
| Howard E. Goodwin | Director | |
| Randall S. Ussery | Director | |
| Caitlyn Krebs | Executive Officer, Director |
Other companies in California that filed recently
- Crosscut SPV Frontier LP - Series 2 $23.4 million · Oct 30, 2026
- Series 23-1, a series of StartEngine Private Funds LLC $314,025 · Oct 30, 2026
- Omnissa Holdco LLC offering · Oct 30, 2026
- Angle Health, Inc. $591.5 million · Oct 29, 2026
- Agilis Medical, Inc. $4 million · Oct 28, 2026
- Bridgeview Innovations, Inc. $10.3 million · Oct 28, 2026
Every Form D from the week of Feb 27, 2023 · All recent filings in California · All recent Other filings
Read from SEC EDGAR. Amount sold is what Nalu Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.